NBGI Ventures sells TPV to Bausch + Lomb

The transaction is expected to be concluded in January 2013.

TPV was founded as a joint venture between German contact lenses company Bausch + Lomb and NBGI portfolio company 20/10 Perfect Vision in September 2011. The joint venture included an option for Bausch + Lomb to buy all outstanding shares upon fulfilling certain criteria, such as earnouts, based on a total enterprise value of €450m.

Company
TPV is a Munich-based medical technology company that focuses on the development and distribution of refractive and cataract technologies used in laser vision correction.

People
Investment director Aris Constantinides led the exit on behalf of NBGI. 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Now researching
• Healthcare
• Exits
• DACH
• NBGI Private Equity
• United Kingdom
• Venture